Présentation
Publications scientifiques
-
2026
Interferon-driven gene signature identifies two distinct subgroups in rheumat..., Rheumatology (Oxford)
-
2026
NAP1 switches from an activator to a limiter of interferon induction by trapp..., Springer Science and Business Media LLC
-
2026
ADAR1 loss-of-function variants altering RNA editing define a new interferon-..., Rockefeller University Press
-
2026
Type I interferon signature does not correlate with disease activity in Blau ..., Springer Science and Business Media LLC
-
2026
Pharmacological stabilization of hypoxia-inducible factor 1-α dampens the int..., Springer Science and Business Media LLC
-
2025
Generation of two iPSC lines from patients with Aicardi-Goutières syndrome ca..., Stem Cell Res
-
2025
Insights from a novel monogenic autoinflammatory disease: overview of a multi..., Ann Rheum Dis
-
2025
Inborn errors of immunity and AAV: a complex picture., Nat Rev Rheumatol
-
2025
Predictive factors of comorbid attention-deficit/hyperactivity disorder in ea..., Pediatr Rheumatol Online J
-
2025
French protocol for diagnosis and management of type 1 interferonopathies., Rev Med Interne
-
2025
International multidisciplinary consensus on the definition and clinical appr..., Pediatr Rheumatol Online J
-
2025
Autoinflammatory encephalopathy due to PTPN1 haploinsufficiency: a case series., Lancet Neurol
-
2024
Functional Validation of a COPA Mutation Broadens the Spectrum of COPA Syndrome., J Clin Immunol
-
2024
Interface Gain-of-Function Mutations in TLR7 Cause Systemic and Neuro-inflamm..., J Clin Immunol
-
2024
Heterozygous mutations in the C-terminal domain of COPA underlie a complex au..., J Clin Invest
-
2023
JAK Inhibition in Aicardi-Goutières Syndrome: a Monocentric Multidisciplinary..., J Clin Immunol
-
2023
Early systemic inflammation induces neurodevelopmental disorders: results fro..., Mol Psychiatry
-
2023
Osteonecrosis in patients with juvenile dermatomyositis: is it associated wit..., Rheumatology (Oxford)
-
2022
Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Nov..., J Clin Immunol
-
2021
JAK inhibition in the type I interferonopathies., J Allergy Clin Immunol
-
2021
Rheumatoid factor positive polyarticular juvenile idiopathic arthritis associ..., Rheumatology (Oxford)
-
2021
STING-Mediated Lung Inflammation and Beyond., J Clin Immunol
-
2021
Differential Expression of Interferon-Alpha Protein Provides Clues to Tissue ..., J Clin Immunol
-
2020
Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among ..., J Allergy Clin Immunol Pract
-
2020
Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics., Curr Rheumatol Rep
-
2019
Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defi..., Rheumatology (Oxford)
-
2018
Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome., N Engl J Med
-
2018
Comment on: 'Aberrant tRNA processing causes an autoinflammatory syndrome res..., Ann Rheum Dis
-
2017
Disease-associated mutations identify a novel region in human STING necessary..., J Allergy Clin Immunol
-
2016
Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease., J Clin Immunol
-
2016
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of va..., J Allergy Clin Immunol
-
2014
Inherited STING-activating mutation underlies a familial inflammatory syndrom..., J Clin Invest